학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 124건 | 목록
1~20
Academic Journal
Bohg C; Research Unit Molecular Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Dubanych Y; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.; Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Prague, Czech Republic.; Kosteletos S; Research Unit Molecular Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Xiao T; Research Unit Molecular Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Neuenschwander M; Core Facility Screening Unit, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Utesch T; Research Unit Structural Chemistry & Computational Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Lisurek M; Research Unit Structural Chemistry & Computational Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Öster C; Research Unit Molecular Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Oder A; Core Facility Screening Unit, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Seyffarth C; Core Facility Screening Unit, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Bach K; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.; Leone DG; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.; Filandr F; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.; Wegert M; Research Unit Biomolecule Modification and Delivery, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Lange S; Research Unit Molecular Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Sawczyc H; Research Unit Molecular Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; von Kries JP; Core Facility Screening Unit, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Hackenberger CPR; Research Unit Biomolecule Modification and Delivery, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Institute of Chemistry, Humboldt-Universität zu Berlin, Berlin, Germany.; Specker E; Core Facility Compound Management, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Sun H; Research Unit Structural Chemistry & Computational Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Institute of Chemistry, Technische Universität Berlin, Berlin, Germany.; Stříšovský K; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.; Lange A; Research Unit Molecular Biophysics, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Institute of Biology, Humboldt-Universität zu Berlin, Berlin, Germany.
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 0370543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3773 (Electronic) Linking ISSN: 14337851 NLM ISO Abbreviation: Angew Chem Int Ed Engl Subsets: MEDLINE
Academic Journal
Wolff C; Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Berlin, Germany. wolff@fmp-berlin.de.; Neuenschwander M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Berlin, Germany.; Müller M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Berlin, Germany.; Mühl A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Berlin, Germany.; von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Berlin, Germany.; Schmied C; EU-OPENSCREEN ERIC, Campus Berlin-Buch, Berlin, Germany. christopher.schmied@eu-openscreen.eu.; Specker E; Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Berlin, Germany. specker@fmp-berlin.de.
Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE
Academic Journal
Mohd S; Structural Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.; Oder A; Screening Unit, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.; Specker E; Screening Unit, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.; Neuenschwander M; Screening Unit, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.; Von Kries JP; Screening Unit, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.; Daumke O; Structural Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Becker PC; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Güth-Steffens M; Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, Bonn, Germany.; Lazarow K; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Sonntag N; Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, Bonn, Germany.; Braun D; Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, Bonn, Germany.; Masfaka I; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Renko K; Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Charite Universitätsmedizin Berlin, Berlin, Germany.; German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment (BfR), Berlin, Germany.; Schomburg L; Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Charite Universitätsmedizin Berlin, Berlin, Germany.; Köhrle J; Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Charite Universitätsmedizin Berlin, Berlin, Germany.; von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Schweizer U; Rheinische Friedrich-Wilhelms-Universität, Universitätsklinikum Bonn, Bonn, Germany.; Krause G; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Protze J; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE
Academic Journal
He J; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.; Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.; Ou K; BIH Center for Regenerative Therapies (BCRT), T Cell Epigenetics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Schmueck-Henneresse M; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health (BIH) At Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Center for Advanced Therapies, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.; Specker E; Chemical Biology Platform, Leibniz-Forschungsinstitut Für Molekulare Pharmakologie (FMP), Berlin-Buch, Germany.; Paul J; Chemical Biology Platform, Leibniz-Forschungsinstitut Für Molekulare Pharmakologie (FMP), Berlin-Buch, Germany.; Nazare M; Chemical Biology Platform, Leibniz-Forschungsinstitut Für Molekulare Pharmakologie (FMP), Berlin-Buch, Germany.; von Kries JP; Chemical Biology Platform, Leibniz-Forschungsinstitut Für Molekulare Pharmakologie (FMP), Berlin-Buch, Germany.; Polansky JK; BIH Center for Regenerative Therapies (BCRT), T Cell Epigenetics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Immuno-Epigenetics, German Rheumatism Research Centre (DRFZ), Berlin, Germany.; Hamann A; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Frischbutter S; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE
Academic Journal
Brenner M; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Zink C; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Witzinger L; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Keller A; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Hadamek K; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Bothe S; Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany.; Neuenschwander M; Leibniz Forschungsinstitut für Molekulare Pharmakologie-FMP, Berlin, Germany.; Villmann C; Institute of Clinical Neurobiology, University Hospital, University of Würzburg, Würzburg, Germany.; von Kries JP; Leibniz Forschungsinstitut für Molekulare Pharmakologie-FMP, Berlin, Germany.; Schindelin H; Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany.; Jeanclos E; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Gohla A; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Mehboob R; Lahore Medical Research Center, Lahore, Pakistan.; National Heart Lung and Blood Institute, National Institute of Health, Bethesda, MD, United States.; Oehme P; Retired, Berlin, Germany.; Anwar T; Lahore Medical Research Center, Lahore, Pakistan.; von Kries JP; Retired, Berlin, Germany.
Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE
Academic Journal
Sane R; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Berlin, Germany.; Seyffarth C; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Kleissle S; Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft, Berlin, Germany.; Neuenschwander M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Frädrich C; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Berlin, Germany.; Renko K; German Federal Institute for Risk Assessment, German Centre for the Protection of Laboratory Animals (Bf3R), Berlin, Germany.; Wirth EK; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Endocrinology and Metabolism, European Reference Network on Rare Endocrine Diseases (ENDO-ERN), Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Berlin, Germany.; Köhrle J; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, Berlin, Germany.
Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE
Academic Journal
Horatscheck A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Krauß M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Bulut H; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany; Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany.; Chambon V; Institut Curie, PSL Research University, Cellular and Chemical Biology Unit, U1143 INSERM, UMR3666 CNRS, 26 rue d'Ulm, 75248 Paris Cedex 05, France.; Zadah MS; Institut Curie, PSL Research University, Cellular and Chemical Biology Unit, U1143 INSERM, UMR3666 CNRS, 26 rue d'Ulm, 75248 Paris Cedex 05, France.; Dransart E; Institut Curie, PSL Research University, Cellular and Chemical Biology Unit, U1143 INSERM, UMR3666 CNRS, 26 rue d'Ulm, 75248 Paris Cedex 05, France.; Peloza K; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Santos KF; Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany.; Robertson MJ; Chemistry, School of Environmental & Life Sciences, The University of Newcastle, Callaghan, NSW 2308, Australia.; Prichard K; Chemistry, School of Environmental & Life Sciences, The University of Newcastle, Callaghan, NSW 2308, Australia.; Miksche S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Radetzki S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Wahl MC; Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany; Helmholtz-Zentrum Berlin für Materialien und Energie, Macromolecular Crystallography, Albert-Einstein-Str. 15, 12489 Berlin, Germany.; McCluskey A; Chemistry, School of Environmental & Life Sciences, The University of Newcastle, Callaghan, NSW 2308, Australia.; Johannes L; Institut Curie, PSL Research University, Cellular and Chemical Biology Unit, U1143 INSERM, UMR3666 CNRS, 26 rue d'Ulm, 75248 Paris Cedex 05, France.; Haucke V; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany; Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany. Electronic address: haucke@fmp-berlin.de.; Nazaré M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany; Helmholtz-Zentrum Berlin für Materialien und Energie, Macromolecular Crystallography, Albert-Einstein-Str. 15, 12489 Berlin, Germany. Electronic address: nazare@fmp-berlin.de.
Publisher: Cell Press Country of Publication: United States NLM ID: 101087697 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4186 (Electronic) Linking ISSN: 09692126 NLM ISO Abbreviation: Structure Subsets: MEDLINE
Academic Journal
Bogum J; Faust D; Zühlke K; Eichhorst J; Moutty MC; Furkert J; Eldahshan A; Neuenschwander M; von Kries JP; Wiesner B; Trimpert C; Deen PM; Rosenthal W; Klussmann E.; VALENTI, Giovanna
Journal of the American Society of Nephrology, 24, 5, pp. 744-58
Journal of the American Society of Nephrology, 24(5): 744-758
Journal of the American Society of Nephrology : JASN
Journal of the American Society of Nephrology, 24(5): 744-758
Journal of the American Society of Nephrology : JASN
Academic Journal
Marongiu GL; Leibniz-Forschungsinstitut fur Molekulare Pharmakologie, Berlin 13125, Germany.; Fink U; Leibniz-Forschungsinstitut fur Molekulare Pharmakologie, Berlin 13125, Germany.; Schöpf F; Leibniz-Forschungsinstitut fur Molekulare Pharmakologie, Berlin 13125, Germany.; Oder A; Leibniz-Forschungsinstitut fur Molekulare Pharmakologie, Screening Unit, Berlin 13125, Germany.; von Kries JP; Leibniz-Forschungsinstitut fur Molekulare Pharmakologie, Screening Unit, Berlin 13125, Germany.; Roderer D; Leibniz-Forschungsinstitut fur Molekulare Pharmakologie, Berlin 13125, Germany.
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Gorenflos López JL; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Humboldt Universität zu Berlin, Department Chemie, Brook-Taylor-Strasse 2, 12489, Berlin, Germany.; Dornan GL; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Boback N; Freie Universität Berlin, Institut für Pharmazie, Biopharmazeutika, Kelchstr. 31, 12169, Berlin, Germany.; Neuenschwander M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Oder A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Kemnitz-Hassanin K; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Schmieder P; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Specker E; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Asikoglu HC; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Berliner Hochschule für Technik (BHT), Seestrasse 64, 13347, Berlin, Germany.; Oberdanner C; TECAN Group Ltd., Untersbergstraße 1a, 5082, Grödig, Austria.; Seyffarth C; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Lauster D; Freie Universität Berlin, Institut für Pharmazie, Biopharmazeutika, Kelchstr. 31, 12169, Berlin, Germany.; Hinderlich S; Berliner Hochschule für Technik (BHT), Seestrasse 64, 13347, Berlin, Germany.; Hackenberger CPR; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.; Humboldt Universität zu Berlin, Department Chemie, Brook-Taylor-Strasse 2, 12489, Berlin, Germany.
Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7633 (Electronic) Linking ISSN: 14394227 NLM ISO Abbreviation: Chembiochem Subsets: MEDLINE
Academic Journal
Aguirre T; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Institut für Chemie, Humboldt-Universität zu Berlin, Berlin, Germany.; Dornan GL; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Hostachy S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Neuenschwander M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Seyffarth C; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Haucke V; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Schütz A; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Fiedler D; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; Institut für Chemie, Humboldt-Universität zu Berlin, Berlin, Germany.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Hentsch A; Leibniz Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany.; Guberman M; Leibniz Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany.; Radetzki S; Leibniz Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany.; Kaushik S; Leibniz Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany.; Huizenga M; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.; He Y; ETH Zürich, Institute of Pharmaceutical Sciences, Vladimir-Prelog-Weg 4, 8093 Zürich, Switzerland.; Contzen J; Charité─Universitätsmedizin Berlin, Center for Stroke Research, 10117 Berlin, Germany.; Charité─Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, 10117 Berlin, Germany.; Kuhn B; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Benz J; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Schippers M; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Paul J; Leibniz Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany.; Leibrock L; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Collin L; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Wittwer M; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Topp A; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; O'Hara F; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Heer D; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Hochstrasser R; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Blaising J; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; von Kries JP; Leibniz Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany.; Mu L; ETH Zürich, Institute of Pharmaceutical Sciences, Vladimir-Prelog-Weg 4, 8093 Zürich, Switzerland.; van der Stelt M; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.; Mergenthaler P; Charité─Universitätsmedizin Berlin, Center for Stroke Research, 10117 Berlin, Germany.; Charité─Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, 10117 Berlin, Germany.; University of Oxford, Radcliffe Department of Medicine, OX3 9DU Oxford, United Kingdom.; Lipstein N; Leibniz Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany.; Grether U; Roche Pharma Research & Early Development, 4070 Basel, Switzerland.; Nazaré M; Leibniz Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 7503056 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5126 (Electronic) Linking ISSN: 00027863 NLM ISO Abbreviation: J Am Chem Soc Subsets: MEDLINE
Academic Journal
Hentsch A; Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.; Guberman M; Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.; Radetzki S; Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.; Kaushik S; Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.; Huizenga M; Leiden Institute of Chemistry (LIC), Universiteit Leiden, Einsteinweg 55, 2333 CC, Leiden, NL.; Paul J; Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.; Schippers M; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Benz J; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Kuhn B; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Heer D; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Topp A; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Esteves Gloria L; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Walter A; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Hochstrasser R; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Wittwer MB; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; von Kries JP; Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.; Collin L; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Blaising J; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; van der Stelt M; Leiden Institute of Chemistry (LIC), Universiteit Leiden, Einsteinweg 55, 2333 CC, Leiden, NL.; Lipstein N; Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.; Grether U; Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, CH.; Nazaré M; Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, 13125, Berlin, GER.
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 0370543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3773 (Electronic) Linking ISSN: 14337851 NLM ISO Abbreviation: Angew Chem Int Ed Engl Subsets: MEDLINE
Academic Journal
Mehboob R; Lahore Medical Research Center and LMRC Laboratories, LLP, Lahore, Pakistan.; von Kries JP; Screening Unit, Leibniz-Research Institute of Molecular Pharmacology (FMP), Berlin, Germany.; Ehsan K; Lahore Medical Research Center and LMRC Laboratories, LLP, Lahore, Pakistan.; Almansouri M; Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.; Bamaga AK; Neurology Division, Pediatric Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.; Neurology Division, Pediatric Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.
Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE
Academic Journal
Jordan P; Max-Delbrück-Center for Molecular Medicine, Cellular Neuroscience, Berlin, Germany.; Costa A; Max-Delbrück-Center for Molecular Medicine, Cellular Neuroscience, Berlin, Germany.; Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States of America.; Specker E; Screening Unit, Leibniz Research Institute for Molecular Pharmacology FMP, Berlin, Germany.; Medicinal Chemistry Research Group, Leibniz Research Institute for Molecular Pharmacology FMP, Berlin, Germany.; Popp O; Max-Delbrück-Center for Molecular Medicine, Mass spectroscopy and Proteomics, Berlin, Germany.; Volkamer A; Dept. of Physiology, In Silico Toxicology and Structural Bioinformatics, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Piske R; Max-Delbrück-Center for Molecular Medicine, Cellular Neuroscience, Berlin, Germany.; Obrusnik T; Max-Delbrück-Center for Molecular Medicine, Cellular Neuroscience, Berlin, Germany.; Kleissle S; Screening Unit, Leibniz Research Institute for Molecular Pharmacology FMP, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, RNAi Platform, Berlin, Germany.; Stuke K; Medicinal Chemistry Research Group, Leibniz Research Institute for Molecular Pharmacology FMP, Berlin, Germany.; Rex A; Centre for Stroke Research, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Neuenschwander M; Screening Unit, Leibniz Research Institute for Molecular Pharmacology FMP, Berlin, Germany.; von Kries JP; Screening Unit, Leibniz Research Institute for Molecular Pharmacology FMP, Berlin, Germany.; Nazare M; Medicinal Chemistry Research Group, Leibniz Research Institute for Molecular Pharmacology FMP, Berlin, Germany.; Mertins P; Max-Delbrück-Center for Molecular Medicine, Mass spectroscopy and Proteomics, Berlin, Germany.; Kettenmann H; Max-Delbrück-Center for Molecular Medicine, Cellular Neuroscience, Berlin, Germany.; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; Wolf SA; Max-Delbrück-Center for Molecular Medicine, Cellular Neuroscience, Berlin, Germany.; Dept. Ophthalmology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
van Hoof S; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany.; Kreye J; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany; Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.; Cordero-Gómez C; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany.; Hoffmann J; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany.; Momsen Reincke S; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.; Sánchez-Sendin E; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany.; Duong SL; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany.; Upadhya M; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK.; Dhangar D; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK.; Michór P; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK.; Woodhall GL; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK.; Küpper M; Oscar Langendorff Institute of Physiology, University of Rostock, Germany, Center of Transdisciplinary Neurosciences Rostock (CTNR), Germany.; Oder A; Screening Unit, Leibniz Forschungsinstitut für Molekulare Pharmakologie, 13125 Berlin, Germany.; Kuchling J; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Neurocure Cluster of Excellence, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.; Koch SP; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Center for Stroke Research Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; NeuroCure Cluster of Excellence and Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin, Germany; Charité 3R, Replace, Reduce, Refine, Charité - Universitätsmedizin Berlin, Germany.; Mueller S; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Center for Stroke Research Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; NeuroCure Cluster of Excellence and Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin, Germany; Charité 3R, Replace, Reduce, Refine, Charité - Universitätsmedizin Berlin, Germany.; Boehm-Sturm P; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Center for Stroke Research Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; NeuroCure Cluster of Excellence and Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin, Germany; Charité 3R, Replace, Reduce, Refine, Charité - Universitätsmedizin Berlin, Germany.; von Kries JP; Screening Unit, Leibniz Forschungsinstitut für Molekulare Pharmakologie, 13125 Berlin, Germany.; Finke C; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Neurocure Cluster of Excellence, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.; Kirschstein T; Oscar Langendorff Institute of Physiology, University of Rostock, Germany, Center of Transdisciplinary Neurosciences Rostock (CTNR), Germany.; Wright SK; Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Birmingham, UK; Department of Paediatric Neurology, The Birmingham Women's and Children's Hospital National Health Service Foundation Trust, Birmingham, UK.; Prüss H; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117 Berlin, Germany; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, 10117 Berlin, Germany; Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany. Electronic address: harald.pruess@charite.de.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8800478 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2139 (Electronic) Linking ISSN: 08891591 NLM ISO Abbreviation: Brain Behav Immun Subsets: MEDLINE
Academic Journal
Wąsińska-Kałwa M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Omran A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Mach L; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Scipioni L; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila 67100 L'Aquila Italy mauro.maccarrone@univaq.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy.; Bouma J; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands.; Li X; iHuman Institute, ShanghaiTech University Shanghai 201210 China.; School of Life Science and Technology, ShanghaiTech University Shanghai 201210 China.; Radetzki S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Mostinski Y; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Schippers M; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com.; Gazzi T; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; van der Horst C; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands.; Brennecke B; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Hanske A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Kolomeets Y; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Guba W; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com.; Sykes D; Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, University of Nottingham Midlands UK.; von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Broichhagen J; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.; Hua T; iHuman Institute, ShanghaiTech University Shanghai 201210 China.; School of Life Science and Technology, ShanghaiTech University Shanghai 201210 China.; Veprintsev D; Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, University of Nottingham Midlands UK.; Heitman LH; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands.; Oddi S; Department of Veterinary Medicine, University of Teramo Via R. Balzarini 1 64100 Teramo Italy soddi@unite.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy.; Maccarrone M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila 67100 L'Aquila Italy mauro.maccarrone@univaq.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy.; Grether U; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com.; Nazare M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.
Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101545951 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2041-6520 (Print) Linking ISSN: 20416520 NLM ISO Abbreviation: Chem Sci
Academic Journal
Jeanclos E; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Schlötzer J; Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany.; Hadamek K; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Yuan-Chen N; Institute of Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Germany.; Alwahsh M; Leibniz-Institut für analytische Wissenschaften-ISAS, Dortmund, Germany.; Institute of Pathology and Medical Research Center (ZMF), University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.; Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.; Hollmann R; Leibniz-Institut für analytische Wissenschaften-ISAS, Dortmund, Germany.; Fratz S; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Yesilyurt-Gerhards D; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Frankenbach T; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Engelmann D; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Keller A; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Kaestner A; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Schmitz W; Department of Biochemistry and Molecular Biology, Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany.; Neuenschwander M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie-FMP, Berlin, Germany.; Hergenröder R; Leibniz-Institut für analytische Wissenschaften-ISAS, Dortmund, Germany.; Sotriffer C; Institute of Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Germany.; von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie-FMP, Berlin, Germany.; Schindelin H; Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany.; Gohla A; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany. antje.gohla@uni-wuerzburg.de.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Von Kries, JP
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어